This cell line is representative of estrogen receptor positive (ER+) invasive ductal breast carcinoma, which is known to be mainly driven by the combined activity of the TFs ESR1, GATA3, and FOXA1 [47]. This evidence concerns the gene ESR1 and invasive ductal breast carcinoma.